Consistent with our previous findings, for all breast cancers combined and for ER+ cancers separately, high CENPI mRNA levels provide a significantly worse prognosis than low CENPI mRNA levels, while no significant difference was observed for ER- breast cancers (Figure 2A). This evidence concerns the gene CENPI and breast carcinoma.